{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:35:10Z","timestamp":1782862510621,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Omerus Corporation","award":["USPHSG DA015760"],"award-info":[{"award-number":["USPHSG DA015760"]}]},{"name":"Omerus Corporation","award":["DA016496"],"award-info":[{"award-number":["DA016496"]}]},{"name":"University Texas Center Medical Branch","award":["DA024923"],"award-info":[{"award-number":["DA024923"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.biopsych.2010.09.032","type":"journal-article","created":{"date-parts":[[2010,11,21]],"date-time":"2010-11-21T09:11:43Z","timestamp":1290330703000},"page":"275-281","source":"Crossref","is-referenced-by-count":49,"title":["Mirtazapine Alters Cue-Associated Methamphetamine Seeking in Rats"],"prefix":"10.1016","volume":"69","author":[{"given":"Steven M.","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Celeste","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2010.09.032_bib1","series-title":"The Economic cost of Methamphetamine Use in the United States, 2005","author":"Nicosia","year":"2009"},{"key":"10.1016\/j.biopsych.2010.09.032_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0028-3908(94)90081-7","article-title":"Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells","volume":"33","author":"Kooyman","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0028-3908(88)90149-9","article-title":"Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers","volume":"27","author":"de Boer","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: A comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pbb.2008.12.022","article-title":"Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor","volume":"92","author":"Kakui","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2010.09.032_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s002130050402","article-title":"Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine","volume":"133","author":"Berendsen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2010.09.032_bib8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine 2C receptors: Differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1471-4159.1999.0731033.x","article-title":"Role of serotonin (2A) and serotonin (2B\/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation","volume":"73","author":"De Deurwaerdere","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.09.032_bib10","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1523\/JNEUROSCI.0112-04.2004","article-title":"Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens","volume":"24","author":"De","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1471-4159.2000.740693.x","article-title":"Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum","volume":"74","author":"Lucas","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2010.09.032_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/syn.20109","article-title":"Modulation of dopamine release by striatal 5-HT2C receptors","volume":"55","author":"Alex","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2010.09.032_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<205::AID-SYN5>3.0.CO;2-D","article-title":"Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat","volume":"36","author":"Gobert","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2010.09.032_bib14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","article-title":"Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission","volume":"113","author":"Alex","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2010.09.032_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/pr.59.07103","article-title":"5-HT receptor regulation of neurotransmitter release","volume":"59","author":"Fink","year":"2007","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2010.09.032_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.biopsych.2010.09.032_bib18","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/156802606778522131","article-title":"Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence","volume":"6","author":"Bubar","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.biopsych.2010.09.032_bib19","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1523\/JNEUROSCI.23-36-11461.2003","article-title":"Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers","volume":"23","author":"Volkow","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.neuroimage.2007.09.059","article-title":"Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues","volume":"39","author":"Volkow","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2010.09.032_bib21","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","article-title":"Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction","volume":"26","author":"Volkow","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.156.1.11","article-title":"Limbic activation during cue-induced cocaine craving","volume":"156","author":"Childress","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2010.09.032_bib23","doi-asserted-by":"crossref","first-page":"12040","DOI":"10.1073\/pnas.93.21.12040","article-title":"Activation of memory circuits during cue-elicited cocaine craving","volume":"93","author":"Grant","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2010.09.032_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/026988119801200103","article-title":"Conditioning factors in drug abuse: Can they explain compulsion?","volume":"12","author":"O'Brien","year":"1998","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.yic.0000166815.83017.d8","article-title":"Mirtazapine in amphetamine detoxification: A placebo-controlled pilot study","volume":"20","author":"Kongsakon","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jsat.2007.12.003","article-title":"Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual","volume":"35","author":"McGregor","year":"2008","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.biopsych.2010.09.032_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hup.935","article-title":"Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: A randomized, double-blind study","volume":"23","author":"Altintoprak","year":"2008","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.pnpbp.2006.02.018","article-title":"Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study","volume":"30","author":"Yoon","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.09.032_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2004.10.005","article-title":"Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification","volume":"29","author":"Liappas","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2010.09.032_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/0269881104040241","article-title":"Mirtazapine improves alcohol detoxification","volume":"18","author":"Liappas","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib31","first-page":"1","article-title":"Clinical evidence for the utility of mirtazapine for relapse prevention in humans dependent upon stimulants and\/or opiates","volume":"661","author":"Rafeyan","year":"2008","journal-title":"2008 Neuroscience Meeting Planner"},{"key":"10.1016\/j.biopsych.2010.09.032_bib32","first-page":"e166","article-title":"Employing mirtazapine to aid benzodiazepine withdrawal","volume":"49","author":"Chandrasekaran","year":"2008","journal-title":"Singapore Med J"},{"key":"10.1016\/j.biopsych.2010.09.032_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.drugalcdep.2006.05.014","article-title":"Nullifying drug-induced sensitization: Behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats","volume":"86","author":"McDaid","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2010.09.032_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2008.08.005","article-title":"Mirtazapine treatment after conditioning with methamphetamine alters subsequent expression of place preference","volume":"99","author":"Herrold","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.biopsych.2010.09.032_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FBP.0b013e3282f62c89","article-title":"Effect of schedule of reinforcement on cue-elicited reinstatement of cocaine seeking behavior","volume":"19","author":"Acosta","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00213-008-1187-7","article-title":"Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats","volume":"199","author":"Rogers","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00213-010-1828-5","article-title":"Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse","volume":"210","author":"Reichel","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib38","first-page":"7","article-title":"In methamphetamine self-administering rats, 5-HT2B\/C antagonism fails to alter meth seeking and meth-induced motor behaviors 2009","volume":"650","author":"Graves","year":"2009","journal-title":"Neuroscience Meeting Planner"},{"key":"10.1016\/j.biopsych.2010.09.032_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s002130000676","article-title":"Influence of individual differences and chronic fluoxetine treatment on cocaine seeking behavior in rats","volume":"155","author":"Baker","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib40","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0091-3057(02)00731-1","article-title":"Effects of 7-OH-DPAT on cocaine seeking behavior and on re-establishment of cocaine self-administration","volume":"72","author":"Fuchs","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2010.09.032_bib41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-006-0625-7","article-title":"CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue- and methamphetamine-induced reinstatement of extinguished methamphetamine seeking behavior in rats","volume":"190","author":"Moffett","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1460-9568.2007.05692.x","article-title":"A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats","volume":"26","author":"Berglind","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.2009.139","article-title":"D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning","volume":"35","author":"Nic Dhonnchadha","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00213-003-1637-1","article-title":"The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat","volume":"172","author":"Paterson","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0028-3908(00)00204-5","article-title":"Both GABA(B) receptor agonist and antagonists decreased brain stimulation reward in the rat","volume":"40","author":"Macey","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0022-3565(24)29546-X","article-title":"Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats","volume":"297","author":"McMahon","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2010.09.032_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(01)01598-9","article-title":"Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine","volume":"436","author":"Munzar","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1037\/a0014592","article-title":"Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine seeking behavior in a rat self-administration model","volume":"123","author":"Nic Dhonnchadha","year":"2009","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2010.09.032_bib49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s00213-006-0346-y","article-title":"Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats","volume":"186","author":"Le","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0091-3057(02)00985-1","article-title":"The 5-HT3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat","volume":"74","author":"Kelley","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2010.09.032_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.104.075952","article-title":"Intracranial self-administration of cocaine within the posterior ventral tegmental area of Wistar rats: evidence for involvement of serotonin-3 receptors and dopamine neurons","volume":"313","author":"Rodd","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2010.09.032_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pneurobio.2007.01.001","article-title":"Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors","volume":"81","author":"Muller","year":"2007","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF02244643","article-title":"Effects of serotonergic manipulations on cocaine self-administration in rats","volume":"110","author":"Peltier","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-008-1259-8","article-title":"Discriminative stimulus properties of the atypical antidepressant, mirtazapine, in rats: A pharmacological characterization","volume":"203","author":"Dekeyne","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2010.09.032_bib55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/FBP.0b013e3282f1c94b","article-title":"Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine seeking behavior in rats","volume":"18","author":"Neisewander","year":"2007","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2010.09.032_bib56","first-page":"35","article-title":"Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats","volume":"57","author":"Filip","year":"2005","journal-title":"Pharmacol Rep"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310010012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322310010012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T03:48:31Z","timestamp":1740714511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322310010012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0006322310010012"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2010.09.032","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}